Integrated Clinical-Molecular Classification of Colorectal Liver Metastases
1. The immune subtype demonstrated an improved progression-free survival (HR 0.37) and overall survival (HR 0.56) compared with the canonical...
1. The immune subtype demonstrated an improved progression-free survival (HR 0.37) and overall survival (HR 0.56) compared with the canonical...
1. Stereotactic body radiotherapy in addition to immune checkpoint inhibitors has similar progression-free survival to immune checkpoint inhibitors alone, with...
1. Progression-free survival was longer in the lazertinib group vs the gefitinib group (20.6 months vs 9.7 months, with HR...
1. In patients with right-sided or RAS/BRAFV600E mutated tumors, the PFS was favorable with FOLFOXIRI plus bevacizumab compared to FOLFOX...
1. Patients who were randomized to neoadjuvant FOLFOX vs standard chemoradiation had similar disease-free and overall survival rates. 2. There...
1. The 5-year overall survival had a hazard ratio of 0.49, and this benefit was generally consistent across subgroups (stage,...
1. The probability of progression-free survival at 12 months was 0.57 in the experimental group (cabozantinib plus nivolumab and ipilimumab)...
1. The median overall survival was 10.8 months in the combination group (FTD–TPI + bevacizumab) and 7.5 months in the...
1. The overall objective response rate was 35.1% in patients with initial measurable disease, all of which were partial responses,...
1. Sotorasib showed prolonged efficacy with a median OS of 12.5 months (33% at 24 months) and an ORR of...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.